Ordinary Adjustment | European Biotech Index (Total Return) (EUR) | Effective Date 8th October 2025
European Biotech Index (Total Return) (EUR):
In the ordinary adjustment, the following composition will be implemented over a period starting on 1st October 2025 cob and ending on 7th October 2025 cob. The new composition will be fully reflected in the index with effective open 8th October 2025:
| ADVANCED MEDICAL SOLUTIONS GROUP PLC |
| ALK-ABELLO A/S |
| AMBU AS CLASS B |
| AVACTA GROUP PLC |
| BAVARIAN NORDIC A/S |
| BIONTECH SE |
| CHEMOMETEC A/S |
| DBV TECHNOLOGIES SA |
| DERMAPHARM HOLDING SE |
| DRAEGERWERK VZ |
| EL.EN. S.P.A. |
| EVOTEC SE |
| FAES FARMA SA |
| GENUS PLC |
| GERRESHEIMER AG |
| GRIFOLS SA CLASS A |
| HIKMA PHARMACEUTICALS PLC |
| LABORATORIOS FARMACEUTICOS R |
| ORION OYJ CLASS B |
| ORYZON GENOMICS |
| OXFORD INSTRUMENTS PLC |
| OXFORD NANOPORE TECHNOLOGIES PLC |
| PHARMA MAR SA |
| PHARMING GROUP NV |
| SARTORIUS AG PREF |
| SWEDISH ORPHAN BIOVITRUM AB |
| VALNEVA SE |
| VITROLIFE AB |